Engage PharmaKonsult
Commercial Advisory
Senior commercial guidance for biotechnology leaders navigating critical decisions from development through launch and commercialization.
Biotechnology Commercialization Consulting
Strategy & organizational build
First Commercial Launch
First-launch strategy & execution
Launch Readiness Assessment
Independent readiness & risk assessment
Commercial Leadership
Leadership, culture & organizational performance
Rare Disease Commercialization
Specialized neuro & rare disease strategy
Commercial Due Diligence
Commercial opportunity & risk evaluation
Why Joseph McCoy
- 30+ years of biopharma leadership spanning commercialization, organizational build-out, and growth
- CEO-level strategic perspective and executive presence, with the ability to engage boards, investors, partners, and senior stakeholders in high-level strategic conversations
- Built commercialization strategies for three emerging companies, including organizational design, launch planning, and market development
- Proven launch leadership, with multiple products achieving #1 market performance
- Deep neuroscience, endocrinology and rare disease expertise across complex, specialty markets
- Experienced in building and leading high-performance organizations with a strong culture of accountability and execution
- Ten-time Pinnacle Club leader, demonstrating a sustained record of commercial performance
- Leadership experience across Pfizer, Lundbeck, SK Life Science, and Xeris, combining large-pharma discipline with emerging-company agility
- Former U.S. Navy Officer, bringing mission-focused leadership, decisiveness, and accountability
Where Biotechnology Leadership Engages PharmaKonsult
Senior commercial perspective on decisions that can shape an asset, its commercialization strategy and the company behind it.
Commercial Decisions from Discovery through Phase 3
Bring commercial perspective into development decisions early—before clinical, market and investment assumptions become difficult to change.
Commercialize, Partner or License?
Evaluate the commercial opportunity, organizational requirements, investment and risk behind one of biotechnology’s most consequential strategic decisions.
Regulatory Pathway & Commercial Impact
Consider how regulatory strategy, indication sequencing, evidence requirements and potential labeling decisions may affect market opportunity and commercialization.
Is Your Culture Ready for What Comes Next?
Growth, clinical milestones and commercialization change organizations. Assess whether leadership, culture and ways of working are prepared for the company’s next stage.
Practice Areas
Four areas of commercial leadership
PharmaKonsult partners with biotechnology CEOs and boards across the commercial decisions that define company value—from culture and leadership through launch, rare disease, and therapeutic specialization.
Strategic Drug Development & Commercialization Advisory
Strategic advisory across rare disease drug development and commercialization—helping leadership make the decisions that increase regulatory success, adoption, partnerships, and long-term value.
A commercial lens across the development continuum—indication priority, evidence, centers and investigators, partnering, and commercialization sequencing.
Learn More
Commercial Leadership, Culture & Organizational Performance
High-performing commercial organizations are built through exceptional leadership, disciplined execution, and a culture of trust and accountability.
We help biotechnology companies recruit and develop leaders, optimize commercial organizations, and build cultures that sustain long-term performance.
Learn More
Neurology Rare Disease Commercialization
Neuroscience rare disease launches face dispersed patients, long diagnostic journeys, and concentrated Centers of Excellence.
Specialized commercial guidance for assets where diagnosis, access, and stakeholder dynamics are uniquely complex.
Learn More
Endocrinology Rare Disease Commercialization
Endocrinology rare disease markets demand precise stakeholder mapping, access planning, and specialty commercial execution.
Strategy and launch approaches built for these therapeutic realities—and for the patients and physicians who depend on them.
Learn More
